234 related articles for article (PubMed ID: 10895368)
21. Kinetics of hepatitis C (HCV) viraemia and quasispecies during treatment of HCV associated cryoglobulinaemia with pulse cyclophosphamide.
Thiel J; Peters T; Mas Marques A; Rösler B; Peter HH; Weiner SM
Ann Rheum Dis; 2002 Sep; 61(9):838-41. PubMed ID: 12176813
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.
Terrier B; Saadoun D; Sène D; Sellam J; Pérard L; Coppéré B; Karras A; Blanc F; Buchler M; Plaisier E; Ghillani P; Rosenzwajg M; Cacoub P
Arthritis Rheum; 2009 Aug; 60(8):2531-40. PubMed ID: 19644879
[TBL] [Abstract][Full Text] [Related]
23. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
Duvoux C; Tran Ngoc A; Intrator L; Hézode C; Germanidis G; Pawlotsky JM; Cherqui D; Dhumeaux D
Transpl Int; 2002 Jan; 15(1):3-9. PubMed ID: 11875606
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus acute quadriparetic vasculitic neuropathy responsive to cyclophosphamide.
Souayah N; Sander HW; Menkes DL; Khella SL
Neurol Neurophysiol Neurosci; 2006 Sep; ():5. PubMed ID: 17260082
[TBL] [Abstract][Full Text] [Related]
26. Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
Bonacci M; Lens S; Londoño MC; Mariño Z; Cid MC; Ramos-Casals M; Sánchez-Tapias JM; Forns X; Hernández-Rodríguez J
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):575-583.e1. PubMed ID: 27725289
[TBL] [Abstract][Full Text] [Related]
27. HCV and cryoglobulinemic vasculitis.
Ferri C; Zignego AL; Giuggioli D; Sebastiani M; Cazzato M; Antonelli A; La Civita L; Fadda P; Longombardo G; Pileri S
Cleve Clin J Med; 2002; 69 Suppl 2():SII20-3. PubMed ID: 12086259
[No Abstract] [Full Text] [Related]
28. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
Garini G; Allegri L; Vaglio A; Buzio C
Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
[TBL] [Abstract][Full Text] [Related]
29. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Delluc A; Piette JC; Cacoub P
Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
[TBL] [Abstract][Full Text] [Related]
31. Cryoglobulinemic vasculitis.
Ferri C; Mascia MT
Curr Opin Rheumatol; 2006 Jan; 18(1):54-63. PubMed ID: 16344620
[TBL] [Abstract][Full Text] [Related]
32. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
33. Cryoglobulinemic vasculitis associated with hepatitis C virus infection. A report of eight cases.
Revenga Arranz F; Díaz Díaz R; Iglesias Díez L; Cassis Herce B; Sánchez Gómez F; Fuertes Ortiz A
Acta Derm Venereol; 1995 May; 75(3):234-6. PubMed ID: 7653186
[TBL] [Abstract][Full Text] [Related]
34. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
[TBL] [Abstract][Full Text] [Related]
35. Treatment of HCV-Related Mixed Cryoglobulinemia.
Giuggioli D; Sebastiani M; Colaci M; Fallahi P; Gragnani L; Zignego AL; Antonelli A; Ferri C
Curr Drug Targets; 2017; 18(7):794-802. PubMed ID: 26302805
[TBL] [Abstract][Full Text] [Related]
36. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.
Levine JW; Gota C; Fessler BJ; Calabrese LH; Cooper SM
J Rheumatol; 2005 Jun; 32(6):1164-7. PubMed ID: 15940780
[TBL] [Abstract][Full Text] [Related]
37. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.
Brijker F; Magee CC; Tervaert JW; O'Neill S; Walshe JJ
Clin Nephrol; 1999 Dec; 52(6):344-51. PubMed ID: 10604641
[TBL] [Abstract][Full Text] [Related]
38. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
[TBL] [Abstract][Full Text] [Related]
39. [Twenty-seven years' activities of the French vasculitis study group (FVSG)].
Guillevin L
Rev Med Interne; 2007 Dec; 28 Suppl 4():S263-5. PubMed ID: 18029060
[No Abstract] [Full Text] [Related]
40. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
